Connor, Clark & Lunn Investment Management (CC&L)’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,962
Closed -$1.32M 1056
2020
Q2
$1.32M Buy
3,962
+599
+18% +$199K 0.01% 547
2020
Q1
$765K Buy
+3,363
New +$765K 0.01% 615